Sort
16,300 grants matching “fatty liver disease”
HDAC1 as a nutrient sensor in the development and progression of NAFLD
$535,421Hang Shi · Georgia State University · R01 · FY2024 · DK
Metabolic impact of fructose restriction in obese children
$535,277Jean-Marc Schwarz · Touro University Of California · R01 · FY2012 · DK
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
$535,203Ira A Tabas · Columbia University Health Sciences · P01 · FY2015 · HL
'Metabolically Activated' Macrophages in Obesity and Insulin Resistance
$535,192Lev Becker · University Of Chicago · R01 · FY2022 · DK
Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration
$535,140Joannes B Hoek · Thomas Jefferson University · R01 · FY2011 · AA
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
$535,049Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2021 · CA
Role of DGAT in Triacyglycerol Metabolism
$535,014Robert V Farese · J. David Gladstone Institutes · R01 · FY2012 · DK
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
$534,995Gerald I Shulman · Yale University · R01 · FY2021 · DK
Nonalcoholic Steatohepatitis Clinical Research Network
$534,941Arun J Sanyal · Virginia Commonwealth University · U01 · FY2011 · DK
Novel FXR-dependent Molecular Mechanisms in the Regulation of Liver Metabolism
$534,759Peter A Edwards · University Of California Los Angeles · R01 · FY2022 · DK
Novel FXR-dependent Molecular Mechanisms in the Regulation of Liver Metabolism
$534,759Peter A Edwards · University Of California Los Angeles · R01 · FY2020 · DK
Novel FXR-dependent Molecular Mechanisms in the Regulation of Liver Metabolism
$534,759Peter A Edwards · University Of California Los Angeles · R01 · FY2019 · DK
Novel FXR-dependent Molecular Mechanisms in the Regulation of Liver Metabolism
$534,759Peter A Edwards · University Of California Los Angeles · R01 · FY2021 · DK
Dysregulation of calcium signaling in the initiation of fatty liver disease
$534,731Paula Bartlett · Rutgers Biomedical And Health Sciences · R01 · FY2024 · DK
Keeping fat out of muscle - Role of Branched Amino AcidsAmino Acids in Insulin Resistance
$534,693Zoltan P Arany · University Of Pennsylvania · R01 · FY2024 · DK
HIV Antiretroviral Therapy and Hepatic Injury
$534,653Kenneth E Sherman · University Of Cincinnati · R56 · FY2014 · AI
Hyperinsulinemia and the pathogenesis of NASH
$534,426Saint Louis University · U01 · FY2004 · DK
Hyperinsulinemia and the pathogenesis of NASH
$534,426Brent A Neuschwander-Tetri · Saint Louis University · U01 · FY2006 · DK
Predicting outcomes in nonalcoholic steatohepatitis with advanced fibrosis
$534,392Arun J Sanyal · Virginia Commonwealth University · R01 · FY2025 · DK
Inhibition of hepatic (V)LDL production by a novel antagonist of carboxyl esterase 1
$534,330Stephen A Duncan · Medical University Of South Carolina · R01 · FY2025 · DK
Weight Loss, Inflammation, and Vascular Remodeling
$534,159Francine K Welty · Beth Israel Deaconess Medical Center · P50 · FY2012 · HL
Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration
$534,102Joannes B Hoek · Thomas Jefferson University · R01 · FY2012 · AA
Quantitative Studies of Metabolic Organ Dynamics
$534,006Richard N. Bergman · University Of Southern California · R37 · FY2009 · DK
The Metabolic Syndrome in Mexican American Children
$533,880Ravindranath Duggirala · Texas Biomedical Research Institute · R01 · FY2007 · HD
Protective role of OPN-High macrophages in NASH
$533,838Natalia Nieto · University Of Illinois At Chicago · R01 · FY2023 · DK